Targeted Therapy and Immunotherapy Response Assessment with F-18 Fluorothymidine Positron-Emission Tomography/Magnetic Resonance Imaging in Melanoma Brain Metastasis: A Pilot Study

by Nghi C. Nguyen, Melissa K. Yee, Abuzar M. Tuchayi, John M. Kirkwood, Hussein Tawbi, Hussein Tawbi, James M. Mountz
Published 2018-02-01

Diagnostic Value of FDG PET/MRI in Females With Pelvic Malignancy—A Systematic Review of the Literature

by Nghi Co Nguyen, Sushil Beriwal, Chan-Hong Moon, Nicholas D'Ardenne, James M. Mountz, Alessandro Furlan, Ashok Muthukrishnan, Balasubramanya Rangaswamy
Published 2020-09-01

Quantifying metabolic heterogeneity in head and neck tumors in real time: 2-DG uptake is highest in hypoxic tumor regions.

by Erica C Nakajima, Charles Laymon, Matthew Oborski, Weizhou Hou, Lin Wang, Jennifer R Grandis, Robert L Ferris, James M Mountz, Bennett Van Houten
Published 2014-01-01

Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects

by James M. Mountz, Charles M. Laymon, Ann D. Cohen, Zheng Zhang, Julie C. Price, Sanaa Boudhar, Eric McDade, Howard J. Aizenstein, William E. Klunk, Chester A. Mathis
Published 2015-01-01

Preclinical Evaluation of F-ML-10 to Determine Timing of Apoptotic Response to Chemotherapy in Solid Tumors

by Emre Demirci MD, Rafay Ahmed MD, Meltem Ocak PhD, Joseph Latoche BS, April Radelet BS, Nicole DeBlasio BS, N. Scott Mason PhD, Carolyn J. Anderson PhD, James M. Mountz MD, PhD
Published 2017-01-01

[18F]FDG, [11C]PiB, and [18F]AV-1451 PET Imaging of Neurodegeneration in Two Subjects With a History of Repetitive Trauma and Cognitive Decline

by David O. Okonkwo, Ross C. Puffer, Davneet S. Minhas, Sue R. Beers, Kathryn L. Edelman, Jane Sharpless, Charles M. Laymon, Brian J. Lopresti, Steven Benso, Ava M. Puccio, Sudhir Pathak, Milos D. Ikonomovic, Milos D. Ikonomovic, Joseph M. Mettenburg, Walter Schneider, Chester A. Mathis, James M. Mountz
Published 2019-08-01